Home » Prescription Drugs 4 » Cellcept Generic Mycophenolate Mofetil
CellCept is used for: Preventing organ rejection following kidney liver or heart transplants. This medicine is used in combination with other medicines. Mycophenolate (mye-koe-FEN-oh-late) belongs to a group of medicines known as immunosuppressive agents. It is used to lower the body's natural immunity in patients who receive organ transplants. CellCept is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal cardiac or hepatic transplants. CellCept should be used concomitantly with cyclosporine and corticosteroids.When a patient receives an organ transplant the body's white blood cells will try to get rid of (reject) the transplanted organ. Mycophenolate works by preventing the white blood cells from getting rid of the transplanted organ.
Buy Cellcept Generic Mycophenolate Mofetil and other Prescription Drugs 4 products online
at Medstore.
789
Buy Online at Medstore - Click Here!
About Cellcept Generic Mycophenolate Mofetil:
Product Type: Prescription Drugs 4
Cellcept ( Generic Mycophenolate Mofetil )
Cellcept (Generic Mycophenolate Mofetil)
Generic Mycophenolate Mofetil
250mg 100 Capsules 500mg 50 Capsules
Generic Mycophenolate Mofetil Cellcept
View more
Prescription Drugs 4
Previous Product Next Product
Online Prescriptions.
Industry News : Marquette General Health System joins Premier healthcare alliance. Marquette General Health System of Marquette, Mich., has joined the Premier healthcare alliance, consisting of more than 2,500 hospitals and 76,000 other healthcare sites, to improve care delivery.
“We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier.”
As a Premier owner, Marquette leverages a national purchasing network delivering industry-leading contract pricing. The not-for-profit health system formerly utilized MedAssets as its national purchasing organization.
Marquette also collaborates and compares performance with other members of the alliance to improve care efficiency while safely reducing waste and costs using the nation's largest clinical, financial and operational database.
"Premier's business model is unique in that it is completely owned by its members and thus accountable to and fully aligned with their goals," said Gary Muller, president & CEO at Marquette. "We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier."
The health system participates in two Premier collaboratives for additional performance improvement opportunities.
As a new member of Premier's ASCEND® (Accelerated Supply Chain Endeavor) program, Marquette aggregates, monitors and analyzes supply chain data to identify improvement opportunities. This includes simplified and consistent purchasing processes, appropriate clinical utilization and specially negotiated contracts. Members of ASCEND have saved $56 million over two years, without sacrificing the quality of care.
To support its purchasing decisions, the health system uses Premier supply chain tools like SpendAdvisor® MySpend™, to easily examine spend data.
MACLAR Klacid
Macrobid (Nitrofurantoin)
Macrodantin (Nitrofurantoin Macrocystals)
MADOPAR Prolopa
Malirid Generic Primaquine
Marvelon Desogestrel Ethinyl Oestradiol
Maxalt (Rizatriptan)
Maximune Invirase
Maxolon Clopra
Maxolon (Metoclopramide)
MEBEX Vermox
Medrol Deltastab
MEFTAL Ponstel
Melalite Forte Cream Aclaro
Melanocyl Uvadex
MELOSET MEL
Memantine NAMENDA
M Enalapril Generic Renitec
Meprate Modus
MESACOL Asacol
Metaspray Nasonex
Metformin Generic Glucophage
Methotrexate
Methycobal Generic Mecobalamin
Metocard XL Toprol XR
METOLAR Betaloc
METOLAR H Selopres
Metpamid Reglan
| 
